Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Dr. Natasha Leighl's Highlights in Lung Cancer from 2012: Developments for EGFR Mutation-Positive NSCLC
Author
Howard (Jack) West, MD

EGFR Mutn Pos NSCLCHere is the first of the awaited podcasts from Dr. Natasha Leighl's presentation on "Highlights in Lung Cancer from 2012".  Dr. Leighl is a longtime friend who is a lung cancer expert at Princess Margaret Hospital in Toronto, Ontario, Canada, and she covered a wide range of topics that represented promising developments in the field for the past year, some of which likely to lead to new treatment options for patients in the clinic over the next few years. 

The first part of her talk covered new information on potential treatment options for patients with advanced NSCLC that has an activating EGFR mutation.  Here's the video and audio versions of the podcast, along with the figures for it.  (We're going to forgo the transcript, since it's a time-consuming process, and I don't think there's a major audience for it -- tell us if there's a clear need for the transcripts for these programs that we're not seeing).

[powerpress]

Dr. Leighl Highlights in LC 2012: Pt 1 EGFR Mutn Pos Audio Podcast

Dr. Leighl Highlights in LC 2012 Pt 1 EGFR Mutn Pos Figures

We've got more parts of her presentation waiting in the wings, so check back for more highlights in lung cancer soon.

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on